Market Closed -
Nyse
04:00:02 2024-05-08 pm EDT
|
5-day change
|
1st Jan Change
|
562.4
USD
|
+0.02%
|
|
+6.10%
|
+3.04%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,699
|
5,444
|
4,350
|
3,587
|
3,071
|
5,235
|
Enterprise Value (EV)
1 |
5,397
|
6,017
|
4,898
|
4,364
|
4,094
|
5,859
|
P/E ratio
|
20.3
x
|
21.4
x
|
16.2
x
|
19.4
x
|
11.2
x
|
13.5
x
|
Yield
|
1.7%
|
1.5%
|
1.91%
|
2.33%
|
2.7%
|
1.62%
|
Capitalization / Revenue
|
2.05
x
|
2.49
x
|
2.16
x
|
1.52
x
|
1.11
x
|
1.94
x
|
EV / Revenue
|
2.36
x
|
2.75
x
|
2.44
x
|
1.85
x
|
1.48
x
|
2.17
x
|
EV / EBITDA
|
14.1
x
|
13.4
x
|
11.6
x
|
11.9
x
|
8.65
x
|
9.79
x
|
EV / FCF
|
38.3
x
|
22.9
x
|
31.7
x
|
64.6
x
|
39.2
x
|
12.4
x
|
FCF Yield
|
2.61%
|
4.37%
|
3.15%
|
1.55%
|
2.55%
|
8.06%
|
Price to Book
|
9.41
x
|
7.97
x
|
5.72
x
|
4.66
x
|
3.96
x
|
4.86
x
|
Nbr of stocks (in thousands)
|
11,404
|
11,189
|
10,921
|
10,467
|
9,871
|
9,590
|
Reference price
2 |
412.1
|
486.5
|
398.3
|
342.7
|
311.1
|
545.8
|
Announcement Date
|
2/19/19
|
2/18/20
|
2/16/21
|
2/15/22
|
2/15/23
|
2/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,290
|
2,190
|
2,011
|
2,356
|
2,765
|
2,698
|
EBITDA
1 |
383.3
|
447.8
|
421.4
|
368.1
|
473
|
598.2
|
EBIT
1 |
311.6
|
360.2
|
337.4
|
283.8
|
390.7
|
520.2
|
Operating Margin
|
13.61%
|
16.45%
|
16.78%
|
12.05%
|
14.13%
|
19.28%
|
Earnings before Tax (EBT)
1 |
290.3
|
331.6
|
331.3
|
247.6
|
347.7
|
489
|
Net income
1 |
234.7
|
254.3
|
270.6
|
190.9
|
279.5
|
388.9
|
Net margin
|
10.25%
|
11.61%
|
13.45%
|
8.1%
|
10.11%
|
14.41%
|
EPS
2 |
20.34
|
22.73
|
24.64
|
17.71
|
27.77
|
40.44
|
Free Cash Flow
1 |
140.8
|
262.9
|
154.3
|
67.55
|
104.4
|
472
|
FCF margin
|
6.15%
|
12%
|
7.67%
|
2.87%
|
3.77%
|
17.49%
|
FCF Conversion (EBITDA)
|
36.72%
|
58.71%
|
36.61%
|
18.35%
|
22.06%
|
78.9%
|
FCF Conversion (Net income)
|
59.97%
|
103.38%
|
57.02%
|
35.38%
|
37.33%
|
121.38%
|
Dividend per Share
2 |
7.000
|
7.300
|
7.600
|
8.000
|
8.400
|
8.850
|
Announcement Date
|
2/19/19
|
2/18/20
|
2/16/21
|
2/15/22
|
2/15/23
|
2/15/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
698
|
574
|
548
|
776
|
1,023
|
624
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.821
x
|
1.281
x
|
1.299
x
|
2.109
x
|
2.162
x
|
1.044
x
|
Free Cash Flow
1 |
141
|
263
|
154
|
67.5
|
104
|
472
|
ROE (net income / shareholders' equity)
|
43%
|
43.4%
|
37.5%
|
25.1%
|
36.7%
|
42.3%
|
ROA (Net income/ Total Assets)
|
11.4%
|
12.6%
|
11%
|
7.9%
|
9.84%
|
13.8%
|
Assets
1 |
2,055
|
2,023
|
2,450
|
2,417
|
2,842
|
2,820
|
Book Value Per Share
2 |
43.80
|
61.10
|
69.60
|
73.50
|
78.60
|
112.0
|
Cash Flow per Share
2 |
6.530
|
12.90
|
11.50
|
8.040
|
7.080
|
11.70
|
Capex
1 |
74.6
|
59.4
|
93.3
|
78.9
|
56.2
|
48.3
|
Capex / Sales
|
3.26%
|
2.71%
|
4.64%
|
3.35%
|
2.03%
|
1.79%
|
Announcement Date
|
2/19/19
|
2/18/20
|
2/16/21
|
2/15/22
|
2/15/23
|
2/15/24
|
|
1st Jan change
|
Capi.
|
---|
| +3.04% | 5.4B | | +5.38% | 105B | | -3.71% | 65.16B | | +51.90% | 42.93B | | +18.29% | 39.48B | | +7.47% | 33.27B | | +10.70% | 19.92B | | +16.99% | 17.49B | | +20.27% | 15.43B | | +10.05% | 15.09B |
Other Commodity Chemicals
|